Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis
Siegel, M.B.; Van Swearingen, A.E.D.; Anders, C.K.
Oncology 28(7): 579; 584-585
2014
ISSN/ISBN: 0890-9091 PMID: 25144277 Document Number: 673285
Document emailed within 1 workday
Related Documents
Uauy, R.; Peirano, P. 1999: Breast is best: human milk is the optimal food for brain development American Journal of Clinical Nutrition 70(4): 433-434Korytova, L.I.; Meshechkin, A.V.; Zhabuna, R.M.; Masliukova, E.A.; Ivanov, V.G. 2011: Brain metastasis in breast cancer Voprosy Onkologii 57(5): 672-674
Nakamura, O.; Matsutani, M.; Nagashima, T.; Ueki, K.; Nakamura, M. 1989: The treatment of brain metastasis from breast cancer Gan no Rinsho. Japan Journal of Cancer Clinics 35(9): 979-982
Moiseenko, V.M.; Barishpol'skaia, I.V.; Orlova, R.V.; Protsenko, S.A.; Ermakova, N.A.; Mikhaĭlichenko, T.D.; Semenova, A.I.; Korytova, L.I.; Zhabina, R.M.; Gonta, E.V. 2004: Perspectives in antineoplastic therapy of breast cancer with brain metastasis Voprosy Onkologii 50(2): 250-252
Nakakuma, T.; Takahashi, K.; Ueno, S.; Kondou, Y.; Kosaka, Y.; Sengoku, N. 2017: A Long-Surviving Case of HER2-Positive Breast Cancer with Brain Metastasis Treated through Multidisciplinary Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1107-1109
Jiang, J.; Xia, M.; Feng, J.-B.; Kong, B.-H. 2007: Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo Zhonghua Fu Chan Ke Za Zhi 42(6): 398-402
Tamura, S.; Takeno, A.; Miki, H.; Uchiyama, C.; Kanemura, T.; Ono, H.; Hamanaka, M.; Suzuki, R.; Nakahira, S.; Nakata, K.; Takeda, Y. 2011: Clinical outcomes in patients with brain metastasis from gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(12): 2093-2096
Cocconi, G.; Salvagni, S.; Passalacqua, R.; Ferrozzi, F.; Camisa, R. 2004: Design and development of new combinations of the CMF agents with taxanes (paclitaxel or docetaxel) in advanced breast cancer: a feasibility study Tumori 90(3): 280-284
Semiglazov, V.F. 1980: Clinical pathogenetic forms of breast cancer (new approaches to planned treatment) Khirurgiia 12: 27-31
Yamada, K.; Kohno, N. 2007: Clinical study of bisphosphonates for bone metastasis in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 352-355
Ostrovtsev, L.D. 1972: Metastasis to the axillary lymph nodes as the first clinical sign of cancer of the breast Khirurgiia 48(5): 13-18
Kelloff, G.J.; Crowell, J.A.; Boone, C.W.; Steele, V.E.; Lubet, R.A.; Greenwald, P.; Alberts, D.S.; Covey, J.M.; Doody, L.A.; Knapp, G.G. 1994: Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute Journal of Cellular Biochemistry. Supplement 20: 55-62
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Mbalaviele, G.; Dunstan, C.R.; Sasaki, A.; Williams, P.J.; Mundy, G.R.; Yoneda, T. 1996: E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model Cancer Research 56(17): 4063-4070
Furukawa, T.; Kubota, T.; Tanino, H.; Oura, S.; Yuasa, S.; Murate, H.; Morita, K.; Kozakai, K.; Yano, T.; Hoffman, R.M. 2000: Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay Anticancer Research 20(5c): 3657-3658
Kubinyi, H. 1998: Combinatorial and computational approaches in structure-based drug design Current Opinion in Drug Discovery and Development 1(1): 16-27
Itoh, S.; Konishi, Y.; Harauchi, D.; Shinoto, M. 1984: Clinical trial of UFT against disseminated breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(11): 2381-2385
Liao, Y.-q.; Xu, B.-h. 2007: Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis Zhonghua Zhong Liu Za Zhi 29(8): 615-618
Fetting, J.H.; Siminoff, L.A.; Piantadosi, S.; Abeloff, M.D.; Damron, D.J.; Sarsfield, A.M. 1990: Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(9): 1476-1482
Morimoto, T.; Komaki, K.; Yamakawa, T.; Tanaka, T.; Konishi, Y.; Uomine, Y.; Miki, H.; Ooshimo, K.; Monden, Y. 1988: Clinical trial of 5'-DFUR in patients with recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(10): 2983-2989